Variables | Total (n = 286) | 1st tertile (n = 94, < 3.6%) | 2nd tertile (n = 96, 3.6–12.0%) | 3rd tertile (n = 96, > 12.0%) | P value |
---|---|---|---|---|---|
Age (year) | 61.0 ± 14.7 | 60.6 ± 15.5 | 62.2 ± 14.8 | 60.2 ± 13.8 | 0.626 |
Male (%) | 180 (63.2) | 58 (62.4) | 57 (59.4) | 65 (67.7) | 0.480 |
MAP (mmHg) | 75.9 ± 13.7 | 78.9 ± 15.7 | 75.7 ± 12.1 | 73.3 ± 12.7 | 0.016 |
APACHE II score | 26.8 ± 7.6 | 24.6 ± 8.3 | 28.0 ± 7.2 | 27.9 ± 7.0 | 0.003 |
SOFA score | 13.1 ± 3.7 | 12.1 ± 4.0 | 13.1 ± 3.8 | 14.1 ± 3.0 | 0.001 |
Charlson comorbidity score | 13.1 ± 2.1 | 13.2 ± 2.2 | 13.0 ± 2.2 | 12.9 ± 1.8 | 0.611 |
RIFLE criteria (%)a | |||||
 Risk | 129 (45.1) | 42 (44.7) | 45 (46.9) | 42 (43.8) | 0.666 |
 Injury | 82 (28.7) | 25 (26.6) | 31 (32.3) | 26 (27.1) |  |
 Failure | 75 (26.2) | 27 (28.7) | 20 (20.8) | 28 (29.2) |  |
Comorbid diseases (%) | |||||
 Hypertension | 111 (38.8) | 40 (42.6) | 43 (44.8) | 28 (29.2) | 0.056 |
 Diabetes mellitus | 98 (34.3) | 42 (44.7) | 32 (33.3) | 24 (25.0) | 0.016 |
Biochemical data | |||||
 DNI (%) | 6.10 (2.73–19.78) | 1.35 (0–2.71) | 6.00 (4.40–8.40) | 27.9 (19.18–43.60) | <0.001b |
 Hemoglobin (g/dL) | 9.6 ± 5.3 | 9.3 ± 2.2 | 9.4 ± 2.1 | 10.3 ± 8.6 | 0.349 |
 WBC (103/mm3) | 11.6 (5.7–18.1) | 13.6 (7.0–17.4) | 13.9 (9.5–20.6) | 7.5 (3.3–17.5) | 0.002b |
 Platelet (103/ mm3) | 86 (51–163) | 112 (62–207) | 100 (61–185) | 57 (41–94) | <0.001b |
 eGFR (mL/min/1.73 m2) | 30.9 ± 17.0 | 27.9 ± 16.0 | 32.3 ± 17.2 | 32.5 ± 17.6 | 0.114 |
 Cholesterol (mg/dL) | 93.2 ± 47.8 | 104.7 ± 51.4 | 94.3 ± 44.8 | 81.4 ± 44.7 | 0.008 |
 Albumin (g/dL) | 2.7 ± 0.6 | 2.8 ± 0.6 | 2.7 ± 0.7 | 2.6 ± 0.6 | 0.088 |
 hs-CRP (mg/L) | 104.6 (34.3–199.8) | 71.4 (19.7–160.1) | 114.5 (44.0–196.8) | 128.3 (35.6–279.9) | 0.126b |
 Total bilirubin (mg/dL) | 1.6 (0.7–3.6) | 1.6 (0.7–4.7) | 1.4 (0.6–3.6) | 1.9 (0.7–3.4) | 0.523b |
 PT (INR) | 1.6 ± 0.7 | 1.6 ± 0.6 | 1.5 ± 0.6 | 1.8 ± 0.8 | 0.003 |
 aPTT (sec) | 48.9 ± 28.0 | 42.0 ± 16.2 | 44.1 ± 22.7 | 59.8 ± 36.9 | <0.001 |